Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard The real brain computer interface opportunity isn’t in the headlines. These 10 stocks are building the systems that make it possible.
Hyperfine Inc (NASDAQ:HYPR) Reports Mixed Q3 2025 Results, Provides Q4 Outlook Hyperfine (HYPR) reported mixed Q3 2025 results, missing revenue and EPS estimates. The stock fell as its Q4 revenue guidance also trailed analyst expectations.
Stay updated with the stocks that are on the move in today's after-hours session. Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Which stocks are experiencing notable movement on Thursday? Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Thursday's session: gap up and gap down stocks Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Stay updated with the stocks that are on the move in today's pre-market session. The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Wednesday's after hours session: top gainers and losers Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Hyperfine Inc (NASDAQ:HYPR) Reports Mixed Q2 2025 Earnings: Revenue Misses but Margins Improve Hyperfine Inc (HYPR) reported mixed Q2 2025 results with $2.7M revenue (+26% QoQ) missing estimates but EPS (-$0.12) beating. Gross margin improved, cash burn reduced. Stock rose 3.9% post-earnings. FDA clearances and clinical progress highlight growth potential.
